Tyvärr är denna artikel enbart tillgänglig på Amerikansk Engelska. For the sake of viewer convenience, the content is shown below in the alternative language. You may click the link to switch the active language.

Emotra is a research and development based medical device company, situated in Gothenburg, Sweden. We develop, clinically document and market our unique objective and quantitative method/product EDOR® for testing depressed patients within the psychiatric care.

A series of clinical studies have proven that the test identifies hyporeactive individuals and that these are more vulnerable for suicide actions than others.

The Emotra AB:s share has been listed on Spotlight Stock Market since 28/06/2013 under the ticker EMOT and is traded through banks and stockbrokers.